Susan Hadley, MD
Family Medicine · Tucson, AZNPI 1437148533
Payments from drug & device makers
Across 13 payments — averaging $338.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$4K
- MDD US Operations, LLC$127
- Indivior Inc.$125
- Braeburn Inc.$122
- Pacira Therapeutics, Inc.$122
- AbbVie$94
- plus $56 from 3 others
What the payments were for
- Speaking & faculty fees$3,75085%
- Food & beverage$64615%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 3 | $3,750 |
| MDD US Operations, LLC | 2 | $127 |
| Indivior Inc. | 1 | $125 |
| Braeburn Inc. | 1 | $122 |
| Pacira Therapeutics, Inc. | 1 | $122 |
| AbbVie | 1 | $94 |
| Johnson & Johnson | 2 | $29 |
| Boston Scientific | 1 | $15 |
| Neurocrine Biosciences, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXPLANON$3,750
- Lucemyra/Lofexidine$125
- SUBLOCADE$125
- BRIXADI$122
- Zilretta$122
How this compares
$4,396 in reported general payments places this provider in the 85th percentile of 2,099 family medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 45 | $56,571 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $13,289 |
| Advair HfaFluticasone Propion/Salmeterol | 15 | $3,696 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 67 | $2,051 |
| Gabapentin | 81 | $2,031 |
| Methadone Hcl | 40 | $1,526 |
| Famotidine | 39 | $1,186 |
| Oxycodone Hcl | 51 | $1,055 |
| Omeprazole | 26 | $1,016 |
| Tizanidine Hcl | 26 | $954 |
| Duloxetine Hcl | 22 | $698 |
| Ondansetron OdtOndansetron | 13 | $660 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $650 |
| Azelastine Hcl | 23 | $482 |
| Fluticasone Propionate | 14 | $430 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Tucson
- Dena PetersenTucson$14.7M
- John McGettiganTucson$8.3M
- Kevin PoundsTucson$1.9M
- Thili KulatilakeTucson$1.8M
- Judith BrownTucson$399K
- Hannah LeslieTucson$228K
- Charles MichieliTucson$111K
- Danielle ArmasScottsdale$73M
- Terry O'ReillyMesa$35.8M
- Shawn SearleChandler$27M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.